-
ECB holds interest rates as strong euro causes jitters
-
Spain, Portugal face floods and chaos after deadly new storm
-
EU close to sealing trade deal with Australia
-
German Cup final to stay in Berlin until 2030
-
What does Iran want from talks with the US?
-
Taming the lion: Olympians take on Bormio's terrifying Stelvio piste
-
Wind turbine maker Vestas sees record revenue in 2025
-
Italy's Casse tops second Olympic downhill training
-
Anti-doping boss 'uncomfortable' with Valieva's coach at Olympics
-
Bitcoin under $70,000 for first time since Trump's election
-
'I am sorry,' embattled UK PM tells Epstein victims
-
England's Brook predicts record 300-plus scores at T20 World Cup
-
Ukraine, Russia swap prisoners, US says 'work remains' to end war
-
Wales' Rees-Zammit at full-back for Six Nations return against England
-
Sad horses and Draco Malfoy: China's unexpected Lunar New Year trends
-
Hong Kong students dissolve pro-democracy group under 'severe' pressure
-
Germany claws back 59 mn euros from Amazon over price controls
-
Germany claws back 70 mn euros from Amazon over price controls
-
VW and Stellantis urge help to keep carmaking in Europe
-
Stock markets drop amid tech concerns before rate calls
-
BBVA posts record profit after failed Sabadell takeover
-
UN human rights agency in 'survival mode': chief
-
Greenpeace slams fossil fuel sponsors for Winter Olympics
-
Greenpeace slams fossel fuel sponsors for Winter Olympics
-
Kinghorn, Van der Merwe dropped by Scotland for Six Nations opener
-
Russia says thwarted smuggling of giant meteorite to UK
-
Salt war heats up in ice-glazed Berlin
-
Liverpool in 'good place' for years to come, says Slot
-
Heathrow still Europe's busiest airport, but Istanbul gaining fast
-
Highest storm alert lifted in Spain, one woman missing
-
Shell profits climb despite falling oil prices
-
Pakistan will seek govt nod in potential India T20 finals clash
-
China shuns calls to enter nuclear talks after US-Russia treaty lapses
-
German factory orders rise at fastest rate in 2 years in December
-
Nigeria president deploys army after new massacre
-
Ukraine, Russia, US start second day of war talks
-
Nepal's youth lead the charge in the upcoming election
-
Sony hikes forecasts even as PlayStation falters
-
Rijksmuseum puts the spotlight on Roman poet's epic
-
Trump fuels EU push to cut cord with US tech
-
Fearless talent: Five young players to watch at the T20 World Cup
-
India favourites as T20 World Cup to begin after chaotic build-up
-
Voter swings raise midterm alarm bells for Trump's Republicans
-
Australia dodges call for arrest of visiting Israel president
-
Countries using internet blackouts to boost censorship: Proton
-
Top US news anchor pleads with kidnappers for mom's life
-
Thailand's pilot PM on course to keep top job
-
The coming end of ISS, symbol of an era of global cooperation
-
New crew set to launch for ISS after medical evacuation
-
Family affair: Thailand waning dynasty still election kingmaker
US cracks down on 'tranq' drug linked to fatal overdoses
The United States announced Tuesday a crackdown on unlawful imports of xylazine, an animal tranquilizer known as the "zombie drug" and which is increasingly linked to overdose deaths.
Xylazine, which also goes by the street name "tranq," has recently been found in illicitly manufactured fentanyl, heroin, cocaine and other drugs, presenting a "growing public health concern," the Food and Drug Administration (FDA) said.
"This action aims to prevent the drug from entering the US market for illicit purposes, while maintaining availability for its legitimate uses in animals," it said in a statement.
According to the National Institute on Drug Abuse, the percentage of all drug overdose deaths involving xylazine increased from two percent to 26 percent in the northeast state of Pennsylvania from 2015 to 2020.
Xylazine is typically used by veterinarians to sedate large animals such as horses and deer but the drug is not approved for use in humans.
It can slow breathing, blood pressure and heart rate to critically low levels and cause skin ulcers and abscesses that can lead to amputation.
The FDA said imports of xylazine would be subject to heightened scrutiny and seized if they appear to be unlawful.
"The FDA remains concerned about the increasing prevalence of xylazine mixed with illicit drugs, and this action is one part of broader efforts the agency is undertaking to address this issue," FDA commissioner Robert Califf said.
N.Fournier--BTB